National Horizons Centre
The National Horizons Centre will provide hands-on training for advanced therapy medicinal products (ATMPs) and vaccine manufacture, focusing on Good Practice (GxP) manufacturing, process development and bioprocessing techniques.Training will be available at the centre starting from May 2021, with courses covering Upstream and Downstream Bioprocessing, Analytical techniques for Bioprocessing, Process Control and Automation, Viral Vector Manufacturing, Biologics Manufacturing, Data Integrity, Computer Systems Validation and IT compliance, Good Manufacturing Practice (GMP) for Biologics, Practical Proteomics, and Flow cytometry for bioprocessing.
Read more about the National Horizons Centre here.
RoslinCT will collaborate with the Scottish Universities Life Sciences Alliance (SULSA) and additional academic institutions to deliver high impact advanced therapy and vaccine manufacturing GMP training.Courses delivered by the RoslinCT Training Academy will include practical and classroom courses on sterile manufacturing in the cleanroom environment at their newly built facility in Edinburgh. The topics covered will include gowning and cleanroom behaviour, environmental monitoring and control, aseptic cell processing, and analytical techniques. Read more about RoslinCT here.
University of Birmingham
The on-site training provided by the University of Birmingham will focus on advanced therapy medicinal product (ATMP) manufacturing and clinical adoption.The first courses from the University of Birmingham will launch in September 2021 covering ATMPs and Good Manufacturing Practice (GMP). The University of Birmingham will also offer master’s degree level modules on GMP standards, which are an essential requirement for the authorisation, manufacture, and commercialisation of ATMPs. The topics covered will include gowning and cleanroom behaviour, environmental monitoring and control, aseptic cell processing, and analytical techniques. Read more about University of Birmingham here.